Hyundai Development Co (294870.KS) stock: key figures, P/E, revenue and dividend
Industrials · Construction & Engineering · South Korea · ISIN KR7294870001
Hyundai Development Co financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.26 tn KRW | 4.15 tn KRW |
| Gross profit | 402.04 bn KRW | 591.69 bn KRW |
| Operating income | 184.64 bn KRW | 248.61 bn KRW |
| EBIT | 255.69 bn KRW | 283.89 bn KRW |
| Net income | 155.72 bn KRW | 158.15 bn KRW |
| Diluted EPS – continuing operations | 2,426.66 KRW | 2,481.11 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hyundai Development Co
IPARK Hyundai Development Company, operates as a financial real estate company, provides real estate services primarily in South Korea. The company is involved in general architecture, civil engineering, outsourced housing, and self-construction activities. The company was formerly known as HDC Hyundai Development Company and changed its name to IPARK Hyundai Development Company in March 2026. IPARK Hyundai Development Company is headquartered in Seoul, South Korea.
More stocks
- Impax Environmental Markets PLC (IEM.L)
- Ivanhoe Electric Inc. (IE)
- Tianrun Crankshaft Co Ltd (002283.SZ)
- Farmers And Merchants Bank of Long Beach (FMBL)
- Sociedad Matriz SAAM SA (SMSAAM.SN)
- Via Transportation, Inc. (VIA)
- Capitalonline Data Service Co Ltd (300846.SZ)
- MilDef Group AB (MILDEF.ST)
- Sparekassen Sjaelland-Fyn A/S (SPKSJF.CO)
- Shenzhen Desay Battery Technology Co Ltd (000049.SZ)
- Uniti Group Inc. (UNIT)
- Changzhou Qianhong Biopharma Co Ltd (002550.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.